Researchers found that patients view physicians who use decision aids as less capable and may assign them responsibility for negative health outcomes when using CDSSs. To mitigate this, healthcare providers can incorporate decision aids to engage patients and facilitate understanding of diagnoses.
Researchers at Stanford University School of Medicine have engineered key immune cells to resist HIV infection by inactivating a receptor gene and inserting additional anti-HIV genes. The new approach, known as 'stacking,' provides multiple layers of protection against the virus and could potentially replace drug treatment.
Dr. Sean B. Rourke, head of the Neurobehavioural Research Unit at St. Michael's Hospital, has received $1.5 million from the Canadian Institutes of Health Research to establish a community-based HIV/AIDS research centre across Canada.
A new study published in the AIDS Journal found that starting antiretroviral therapy (ART) for HIV can lead to reduced food insecurity among patients. The treatment improved work status and mental health, resulting in decreased hunger rates, with the most pronounced effects seen in those receiving ART.
A new study published in AIDS Journal found that HIV subtype distribution is strongly influenced by spatial accessibility and transportation networks in Africa. The research used advanced mapping techniques to assess the role of 'spatial connectivity' in the spread of HIV across sub-Saharan Africa.
Routine HIV testing can significantly reduce AIDS-related morbidity and death, as well as HIV transmission. Implementing this strategy would provide a roadmap for an AIDS-free generation.
Researchers at Wits University and Centre for the Aids Programme of Research in South Africa have discovered a unique feature of HIV that enables infected people to create potent antibodies. These broadly neutralizing antibodies can kill up to 88% of HIV types, providing an important new approach for developing an AIDS vaccine.
Grandmothers Against Poverty and AIDS (GAPA) empowers grandmothers caring for HIV/AIDS-affected families with peer support, income-generating activities. Studies show GAPA members experience higher self-esteem and reduced poverty, stigma in their community.
Researchers found a large number of previously undescribed viruses in the gastrointestinal tract of monkeys with SIV-induced AIDS, suggesting these viruses may contribute to disease progression. The presence of RNA viruses alongside DNA viruses offers new insights into the complex interplay between microorganisms and disease.
A team of scientists will enroll 250 people living with HIV/AIDS in a clinical study to compare an intervention with a Holistic Health Recovery Program adapted for Alcohol Use Disorders, aiming to enhance patients' awareness and modify behaviors that promote HIV disease progression.
Researchers evaluated MDHearingAid's acoustic properties and tested it on patients with mild to moderately-severe hearing loss. The study found the device to be electroacoustically adequate and a reasonable low-cost solution for those who cannot afford custom hearing aids.
People with AIDS are at increased risk for developing esophageal and stomach carcinoma, as well as non-Hodgkin lymphomas. The study found that those with AIDS had a 69% increased risk of esophageal cancer and a 53% increased risk of lower stomach cancer.
A UC San Diego study has identified a human gene called Human Schlafen 11 that produces a protein blocking the replication of HIV in infected cells. The research may lead to diagnostic tests and therapeutic drugs to prevent AIDS progression.
A team of researchers has identified a possible key to slowing the progression towards AIDS by uncovering an early immune response that targets a specific section of the HIV protein. This novel finding could lead to new insights into vaccine design and may provide hope for better treatment options for those living with HIV.
Jon Cohen, a contributing correspondent for Science magazine, has won the Victor Cohn Prize for his exceptional coverage of biomedical topics and chronicling of the global HIV/AIDS epidemic. He will receive the prize at an awards ceremony on October 27 in Raleigh, North Carolina.
Scientists at Gladstone Institutes have developed a method to precisely track the life cycle of individual cells infected with HIV, targeting 'HIV latency'. This breakthrough could help advance the discovery of a cure for AIDS by understanding and interrupting the dormant virus.
Despite negative stereotypes, religious groups in Africa promote medical solutions and provide care for those affected by HIV/AIDS. Many congregations actively engage both faith and biomedical approaches to address the epidemic.
Researchers at OHSU's Vaccine and Gene Therapy Institute studied the mechanism behind protection offered by slightly weakened monkey AIDS virus versions that were too risky for human use. The study reveals that anti-viral T cells in lymphoid tissue are responsible for this protection, which is lost when the virus is further weakened.
Group Health's video-based decision aids for arthritis patients led to a sharp decline in knee and hip replacement surgeries by 38% and 26%, respectively, over six months. The cost of caring for those patients also decreased by 12-21%.
A study published in AIDS Patient Care and STDs found that HIV-specialized community pharmacies can significantly improve treatment adherence among patients. Users of these pharmacies had greater persistence with their antiviral drug regimens compared to those using traditional pharmacies.
A meta-analysis of clinical trials found no statistically significant differences in viral load after 48 weeks between women and men with HIV. However, subgroup analyses revealed significant gender differences favoring males in certain outcomes.
A landmark HIV treatment-as-prevention study has found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays AIDS-related health events such as chronic herpes simplex virus and tuberculosis. Earlier treatment is also cost-effective as it increases survival, prevents...
The HPTN 052 study found that early antiretroviral therapy significantly delayed the time to both AIDS and non-AIDS primary events and reduced the overall incidence of clinical events. Immediate ART also decreased the incidence of clinical events likely due to reversal of immune suppression.
Dr. Warner C. Greene and global AIDS experts release a locally affordable version of the world's leading AIDS medical textbook, designed specifically for resource-poor regions. The textbook features up-to-date clinical information on HIV/AIDS, including managing and treating the disease in resource-poor settings.
A multifaceted global effort could lead to an AIDS-free generation by expanding testing, treatment, and prevention programs. Combination antiretroviral therapy has significantly improved health and longevity for individuals infected with HIV, saving an estimated 700,000 lives globally in 2010.
A new collaboration between DNDi and Cipla aims to develop a 4-in-1 ARV combination product for young children with HIV/AIDS, addressing the gap in current treatments. The goal is to provide safe, potent, child-friendly treatment combinations to accelerate care provision for infants and toddlers living with HIV/AIDS.
A new study from Lund University in Sweden has found that co-infection with mild HIV-2 can slow the development of AIDS in HIV-1-infected patients. The study suggests that HIV-2 can activate cellular reactions that naturally check the development of AIDS, leading to better preventive measures and treatments.
A new report identifies seven key areas where funding and political will are crucial to ending the AIDS epidemic. The report outlines a comprehensive plan for achieving an AIDS-free generation, including renewed scientific research and implementation of proven treatment tools.
Researchers will explore ways to induce protective IgA human antibodies by vaccines to prevent HIV-1 infection, and produce recombinant IgAs to be tested as therapies.
A recent study by Clemson University psychologist Richard Pak found that humanizing computer aids can significantly alter perceptions of their reliability, leading to increased trust and dependence among adults. The design of decision-support aids on consumer devices plays a crucial role in shaping user behavior.
Tel Aviv University has equipped a bio-safety lab with state-of-the-art equipment to research HIV/AIDS, developing novel therapies and diagnostic tools. The ASHA grant supports researchers studying the virus's mechanisms, host interactions, and co-infections.
The Scripps Research Institute has been awarded a grant to develop a vaccine against HIV and the disease it causes, AIDS. The Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID) will conduct multidisciplinary research into immune responses that prevent infection or control the virus in infected individuals.
The Lifespan/Tufts/Brown Center for AIDS Research has received a $8.5 million, five-year renewal grant from the National Institutes of Health to support interdisciplinary collaboration and shared resources among over 60 investigators from various fields.
A new project aims to increase hearing aid use by providing easy-to-use video tutorials that address common barriers to adoption. The tutorials offer practical tips, animations, and real-life experiences from users to support patients in making the most of their devices.
Researchers found that abacavir induces the creation of drug-induced immunogens that are attacked by the immune system, leading to severe hypersensitivity reactions. This autoimmune mechanism is similar to those causing diseases like lupus and type 1 diabetes.
A new study by Stanford University School of Medicine researchers found that the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) contributed to a significant decline in adult death rates from all causes in Africa. The program saved over 740,000 lives between 2004 and 2008 in nine countries targeted by PEPFAR.
Researchers conducted a 10-year retrospective study on HIV patients in San Francisco, finding that they suffered sudden cardiac death at a rate four times higher than the general population. The study suggests that HIV changes the electrophysiology of the heart, increasing the risk of conduction abnormalities and sudden death.
A study on Rwanda found that HIV/AIDS funding has no adverse effects on non-AIDS health services, and may even improve overall quality of care. The research suggests that comprehensive HIV/AIDS interventions can provide better preventive care, including superior delivery of childhood vaccinations.
Researchers found that HIV-1 replication in human tissues increases with a single amino acid change in the Gag protein. This adaptation is crucial for efficient viral replication and may have played a role in the emergence of HIV/AIDS.
Researchers study the origins of HIV/AIDS, revealing that SIV replication in human tissues is crucial to viral efficiency. In contrast, a new study finds that autoantibodies against citrullinated proteins contribute to bone loss in rheumatoid arthritis patients.
Researchers at Simon Fraser University have received a $2.7 million funding boost to enhance the effectiveness of their DNA-based HIV/AIDS vaccine. The team aims to strengthen a vaccine targeting the MPER region, a highly prized site for antibody production.
Researchers found that HIV in semen persists among sexually active HIV-infected MSM on HAART, posing a transmission risk. Detection of HIV in semen was strongly associated with high-risk behavior and genital inflammation.
A cost-utility analysis shows the DC Female Condom program prevented significant HIV infections and saved over $8 million in future medical care costs. The program's success suggests promoting female condoms as an effective HIV prevention intervention for women at high risk.
A study found that CD4 cell count is associated with AIDS risk in HIV-infected adults on combination antiretroviral therapy (cART) with a suppressed viral load. Patients with higher CD4 counts have lower AIDS risk, even at counts above 500 cells/μL.
Researchers at Mount Sinai School of Medicine discovered that marijuana-like chemicals trigger receptors on human immune cells that directly inhibit a type of human immunodeficiency virus (HIV) found in late-stage AIDS. This finding could lead to the development of new drugs to slow the progression of disease.
Research from UCSF and Harvard Medical School finds that trauma significantly contributes to the HIV epidemic among women. Women with HIV are exposed to trauma at higher rates than the general population, leading to post-traumatic stress disorder (PTSD) and poor treatment outcomes.
The International Association of Physicians in AIDS Care published new evidence-based guidelines to overcome barriers to optimal HIV care. The guidelines address key areas such as entry into care, monitoring adherence, and education, with a focus on special populations like children and adolescents.
A study has revealed that eight new diseases, including herpes zoster and certain forms of cancer, can serve as indicators for undiagnosed HIV. The findings highlight the importance of earlier testing and diagnosis to improve survival rates and quality of life among infected individuals.
African-American women are disproportionately affected by HIV/AIDS in the US, with 44% of new infections attributed to this group. The NC State project seeks to improve prevention materials targeting African-American female college students through culturally relevant messaging and language strategies.
The authors argue that HAART roll-out's cost-effectiveness has been significantly understated, as economic analyses fail to account for its role in preventing HIV transmission. This oversight highlights the need for expanded 'Seek, Test, Treat and Retain' programs to control HIV and AIDS-related morbidity, mortality, and transmission.
A CWRU study reveals that pet ownership helps women manage their HIV/AIDS through social roles such as advocate, pet owner, and faith believer. The research highlights the importance of these lesser-known roles in self-management behavior.
New guidelines from the American Academy of Neurology provide treatment recommendations for people with HIV/AIDS taking seizure drugs. The guidelines aim to prevent drug interactions that could make HIV drugs less effective or lead to a more virulent strain of the disease.
A new guideline issued by the American Academy of Neurology recommends caution when selecting seizure medications for individuals with HIV/AIDS due to the risk of adverse interactions. The guideline aims to minimize the impact of these drug combinations, particularly in developing countries where treatment options are limited.
The HPTN 052 study found that early treatment with antiretroviral therapy can reduce HIV transmission in couples by at least 96%. The research has been recognized as a scientific breakthrough of the year, inspiring efforts to end the world's AIDS epidemic.
Gladstone and UCSF scientists have discovered how HIV commandeers human proteins to weaken the body's defenses and enhance virulence. The study identifies a key interaction between HIV protein Vif and the human protein CBFß, which enables the virus to infect CD4 T cells.
The Canadian Medical Association Journal article argues that routine HIV disclosure prosecutions are unnecessary and harmful. With highly active antiretroviral therapy (HAART), the transmission of HIV from treated individuals is now extremely low, making criminal prosecution ineffective in preventing infection.
Scientists at Gladstone Institutes have discovered protein fragments in semen that enhance HIV's ability to infect new cells. Removing these components from semen diminishes HIV's infection potential, suggesting a new approach to preventing transmission.
Experts emphasize the need to treat multiple diseases simultaneously, as common in sub-Saharan Africa, for better outcomes and cost-effectiveness. Studies show that addressing co-infections can significantly reduce HIV transmission risk and viral load.
A team of scientists has identified the 'key' that HIV uses to enter cells' nuclei, allowing it to disable the immune system and cause AIDS. By targeting proteins in the host rather than the virus itself, researchers hope to develop more effective anti-AIDS drugs against drug-resistant strains.
The UCSF Center for AIDS Prevention Studies will receive funding to tackle two primary goals of the National AIDS Strategy: increasing access to care and optimizing health outcomes. The program aims to close gaps in HIV testing, linkage to care, and treatment success among high-risk populations.